News

You are here:

Home
News

Global Specimen Validity Testing Market 2020-2024 | Evolving Opportunities with Abbott Laboratories and Alfa Scientific Designs Inc. | Technavio

April 28, 2020

LONDON–(BUSINESS WIRE)–The global specimen validity testing market is expected to grow by USD 393.04 million as per Technavio. This marks a significant market slowdown compared to the 2019 growth estimates due to the impact of the COVID-19 pandemic in the first half of 2020. However, steady growth is expected to continue throughout the forecast period,…

Details

Abacus Health Products Reports Fourth Quarter and Year-End 2019 Financial Results

April 29, 2020

TORONTO–(BUSINESS WIRE)–Abacus Health Products, Inc. (CSE:ABCS)(OTCQB:ABAHF) (“Abacus” or the “Company”) reported its financial results today for the fourth quarter and year ended December 31, 2019. All amounts are in U.S. dollars unless indicated otherwise. Subsequent event: Proposed Acquisition of Abacus by Charlotte’s Web Holdings, Inc. On March 22, 2020, the Company entered into a definitive…

Details

Xtraction Services Reports Financial Results for the Year Ended 2019

April 29, 2020

LOS ANGELES–(BUSINESS WIRE)–Xtraction Services Holding Corp., (“Xtraction Services”, “XS” or the “Company”) (CSE: XS) (OTCQB: XSHLF) a specialty finance company engaged in equipment leasing in the United States, announced today results for the year ending December 31, 2019 (“YE/19”). The Company’s audited year-end condensed Financial Statements (“FS”) and Management Discussion & Analysis (“MDA”) are available…

Details

Outlook on the Worldwide Free From Food Market to 2026 – Opportunity Analysis and Industry Forecast – ResearchAndMarkets.com

April 29, 2020

DUBLIN–(BUSINESS WIRE)–The “Free from Food Market by Type and Distribution Channel: Global Opportunity Analysis and Industry Forecast 2019-2026” report has been added to ResearchAndMarkets.com’s offering. Free from food products are known as the products in which certain ingredients are removed to make them healthier and safer for consumption. They may be dairy-free, sugar-free, carb-free, lactose-free,…

Details

Lazarus Naturals to Produce Two Million Bottles of Hand Sanitizer to Support COVID Relief Efforts, Gives 8,000 CBD Care Packages to Frontline Workers

April 29, 2020

PORTLAND, Ore.–(BUSINESS WIRE)–Lazarus Naturals, makers of effective, affordable CBD products, has converted production space to make and distribute hand sanitizer to customers, healthcare, and correctional institutions. Ten percent of all sanitizer produced by the company will be donated to food banks and homeless shelters in Portland, Seattle and Central Oregon, where Lazarus Naturals hemp farms…

Details

NantKwest and ImmunityBio to Present at the Bank of America Merrill Lynch Global Healthcare Conference

April 29, 2020

EL SEGUNDO, Calif.–(BUSINESS WIRE)–NantKwest, Inc. (NASDAQ: NK) and ImmunityBio, Inc., today announced that Patrick Soon-Shiong, M.D., Chairman and CEO of both companies, will present at the virtual Bank of America Merrill Lynch Global Healthcare Conference on May 14, 2020 at 4:20 pm ET. A live audio webcast of the conference presentation will be available on…

Details

Quidel to Present Virtually at the BofA Securities 2020 Health Care Conference

April 29, 2020

SAN DIEGO–(BUSINESS WIRE)–Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it will present at the BofA Securities 2020 Health Care Conference, to be held virtually on Wednesday, May 13, 2020. Douglas Bryant, president and chief executive officer, and Randy Steward, chief financial…

Details

Terrace Global Files for the Year Ended December 31, 2019

April 29, 2020

TORONTO–(BUSINESS WIRE)–Terrace Global Inc. (“Terrace Global” or the “Company”) (TSXV:TRCE) is pleased to announce it has filed its audited financial results for the year ended December 31, 2019. The audited financial statements and management discussion and analysis for the three months and year ended December 31, 2019, will be available on the System for Electronic…

Details

Goldfinch Bio Expands Executive Leadership Team

April 30, 2020

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Goldfinch Bio, a U.S.-based, clinical stage biotechnology company focused on discovering and developing precision medicines for the treatment of kidney disease, today announced the appointment of Kyle Kuvalanka as Chief Financial and Operating Officer and the promotion of Lori Rudolph-Owen, Ph.D., from Senior Vice President, R&D Strategy and Operations to Chief Development Officer,…

Details

Court Significantly Reduces Scope of Class Action

April 30, 2020

MONCTON, New Brunswick–(BUSINESS WIRE)–The Nova Scotia Court of Appeal has partially overturned the certification of a class action (the “Class Action”) against Organigram Inc. (the “Company” or “Organigram”) and its parent company Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), a leading licensed producer of cannabis in Canada, on April 30, 2020 thereby significantly reducing the…

Details

22nd Century Group Completes Successful Non-GMO Very Low Nicotine Content Tobacco Research Field Trials

April 30, 2020

WILLIAMSVILLE, N.Y.–(BUSINESS WIRE)–22nd Century Group, Inc. (NYSE American: XXII) (“22nd Century” or “the Company”), a leading plant biotechnology company focused on reduced nicotine tobacco and hemp/cannabis plant genetics research and development, announced today that the Company and North Carolina State University (“NCSU”), have completed successful research field trials that have validated new non-GMO (genetically modified…

Details

SOL Global Provides Update on Timing of Filing of Financial Statements for 2019 and First Quarter 2020

May 1, 2020

TORONTO–(BUSINESS WIRE)–SOL Global Investments Corp. (“SOL Global” or the “Company“) (CSE: SOL) (OTCPK: SOLCF) (Frankfurt: 9SB) wishes to provide an update on its financial reporting for the eight-month audited period ended November 30, 2019 and the three-month interim period ended February 29, 2020. On March 23, 2020, the Ontario Securities Commission issued Ontario Instrument 51-502,…

Details